- Report
- July 2025
- 132 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- June 2025
- 89 Pages
North America
From €3102EUR$3,450USD£2,659GBP
- Report
- June 2025
- 81 Pages
Middle East, Africa
From €3102EUR$3,450USD£2,659GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3551EUR$3,950USD£3,045GBP
- Report
- June 2025
- 100 Pages
Europe
From €3551EUR$3,950USD£3,045GBP
- Report
- June 2025
- 109 Pages
Global
From €3102EUR$3,450USD£2,659GBP
- Report
- June 2025
- 81 Pages
From €3102EUR$3,450USD£2,659GBP
- Report
- June 2025
- 198 Pages
Global
From €4451EUR$4,950USD£3,815GBP
- Report
- June 2025
- 90 Pages
United States
From €1797EUR$1,999USD£1,541GBP
- Report
- May 2025
- 600 Pages
Global
From €1259EUR$1,400USD£1,079GBP
- Report
- May 2025
- 600 Pages
Global
From €1259EUR$1,400USD£1,079GBP
- Report
- April 2025
- 225 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Report
- April 2025
- 44 Pages
United States
- Report
- March 2025
- 145 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- March 2025
- 260 Pages
Middle East
From €2607EUR$2,900USD£2,235GBP
- Report
- March 2025
- 260 Pages
Africa
From €2607EUR$2,900USD£2,235GBP
- Report
- March 2025
- 210 Pages
Latin America
From €2607EUR$2,900USD£2,235GBP
- Report
- March 2025
- 840 Pages
Asia Pacific
From €2607EUR$2,900USD£2,235GBP
- Report
- March 2025
- 980 Pages
Europe
From €2607EUR$2,900USD£2,235GBP
- Report
- March 2025
- 1400 Pages
Global
From €4406EUR$4,900USD£3,777GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more